Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|March 26, 2010
Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifenPhilipp Y Maximov, Cynthia B Myers, Ramona F Curpan, et al.
Endocrine-Related Cancer|November 23, 2017
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancersPhilipp Y Maximov, Balkees Abderrahman, Ramona F Curpan, et al.
Discovery Medicine|June 30, 2016
Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancerV Craig Jordan, Ping Fan, Balkees Abderrahman, et al.
Journal of Medicinal Chemistry|May 9, 2014
Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cellsPhilipp Y Maximov, Daphne J Fernandes, Russell E McDaniel, et al.
Journal of Molecular Graphics & Modelling|January 12, 2026
Selectivity analysis of CDK2 inhibitors via molecular dynamics of CDK1 and CDK2Dmitrii O Shkil, Anastasia S Fokina, Dariy T Asainov, et al.
Journal of the National Cancer Institute|September 27, 2014
Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patientsPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
British Journal of Pharmacology|July 31, 2014
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypesPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Molecular Cancer Research : MCR|June 28, 2015
Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer CellsPing Fan, Heather E Cunliffe, Philipp Y Maximov, et al.
Molecular Pharmacology|August 14, 2020
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Exploration of Targeted Anti-Tumor Therapy|November 19, 2020
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancerMilene Volpato, Michele Cummings, Abeer M Shaaban, et al.
Pageof 3